COMMUNIQUÉS West-GlobeNewswire

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 15:00

FREEHOLD, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, [...]

Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)

03/09/2024 - 15:00

On-going Phase 2b clinical trial (ELPIS II) deemed pivotal and, if positive, acceptable for Biological License Application (BLA) submission for potential full traditional approval Alignment with FDA on ELPIS II primary [...]

Kronos Bio Announces Participation in Medical and Investor Conferences in September

03/09/2024 - 14:55

SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven [...]

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress

03/09/2024 - 14:53

ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its technology will be [...]

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 14:45

ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year [...]

Y-mAbs to Participate in Upcoming Investor Conferences in September

03/09/2024 - 14:32

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

03/09/2024 - 14:31

AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it has been invited to present at the [...]

Avenue Therapeutics to Participate in Upcoming Investor Conferences

03/09/2024 - 14:30

MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the [...]

CVRx Announces Appointment of Two New Board Members

03/09/2024 - 14:30

Kevin Ballinger and Mitch Hill appointed as new independent Board members MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced [...]

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 14:30

ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, [...]

Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 14:30

NORCROSS, Ga., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that Joel Lewis, Chief Executive Officer [...]

Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees

03/09/2024 - 14:30

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader in non-invasive drug testing technology, today announced significant growth in its customer [...]

Tenaya Therapeutics to Participate in Upcoming Investment Conferences

03/09/2024 - 14:30

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]

Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)

03/09/2024 - 14:30

10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort A: 6 patients were treated with azer-cel and lymphodepletion (chemotherapy) 1 Cohort B: 4 patients [...]

Better Choice Company Signs Definitive Agreement to Acquire SRx Health for Approximately $125 Million

03/09/2024 - 14:30

Combined company will emerge as a leading global health and wellness company by providing products and solutions for families to make better choices Combined company net revenue totaled approximately $95 million for the [...]

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

03/09/2024 - 14:29

NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of Lives MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on [...]

Senti Bio to Participate in Upcoming Investor Conferences

03/09/2024 - 14:15

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a biotechnology company developing next-generation cell and gene therapies using its [...]

STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 14:15

HORSHAM, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03/09/2024 - 14:05

SANTA ANA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]